Study S002651

PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02105792
Acronym: PROMASTER
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 820
Start: 2013-03
Primary completion: 2015-05
Lead sponsor: Royal Devon and Exeter NHS Foundation Trust
Conditions: Diabetes
Interventions: DRUG:second- or third-line glucose-lowering diabetes treatment
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER:12/SW/0347

Registered primary outcomes

Response to diabetes therapy [Up to 9 months from commencement of new therapy]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.